pI: 9.4578 |
Length (AA): 168 |
MW (Da): 19393 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 1214 | 6en4 (A) | 1 | 1199 | 66.00 | 0 | 1 | 1.757 | -0.34 |
441 | 764 | 2b5n (A) | 392 | 707 | 27.00 | 0 | 1 | 0.593886 | -0.34 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128558)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G55220 | spliceosome-associated protein 130B |
Arabidopsis thaliana | AT3G55200 | spliceosomal associated protein 130A |
Babesia bovis | BBOV_II004270 | splicing factor 3b, subunit 3, 130kD, putative |
Brugia malayi | Bm1_19455 | splicing factor 3B subunit 3 |
Candida albicans | CaO19.12846 | similar to U2 snRNP complex splicing factor SF3b subunit SAP130 and to S. cerevisiae RSE1 (YML049C) |
Candida albicans | CaO19.5391 | similar to U2 snRNP complex splicing factor SF3b subunit SAP130 and to S. cerevisiae RSE1 (YML049C) |
Caenorhabditis elegans | CELE_K02F2.3 | Protein TEG-4 |
Cryptosporidium hominis | Chro.80487 | CG13900 gene product |
Cryptosporidium parvum | cgd8_4240 | possible spliceosome factor |
Dictyostelium discoideum | DDB_G0282569 | CPSF domain-containing protein |
Drosophila melanogaster | Dmel_CG13900 | CG13900 gene product from transcript CG13900-RA |
Echinococcus granulosus | EgrG_000633300 | splicing factor 3b subunit 3 |
Entamoeba histolytica | EHI_144720 | CPSF A subunit region protein, putative |
Echinococcus multilocularis | EmuJ_000633300 | splicing factor 3b subunit 3 |
Homo sapiens | ENSG00000189091 | splicing factor 3b, subunit 3, 130kDa |
Loa Loa (eye worm) | LOAG_03297 | hypothetical protein |
Mus musculus | ENSMUSG00000033732 | splicing factor 3b, subunit 3 |
Neospora caninum | NCLIV_031340 | Splicing factor 3B subunit 3, putative |
Oryza sativa | 4328237 | Os02g0137400 |
Onchocerca volvulus | OVOC11814 |
|
Plasmodium berghei | PBANKA_1449400 | splicing factor 3B subunit 3, putative |
Plasmodium falciparum | PF3D7_1234800 | splicing factor 3B subunit 3, putative |
Plasmodium knowlesi | PKNH_1454200 | splicing factor 3B subunit 3, putative |
Plasmodium vivax | PVX_100690 | splicing factor 3B subunit 3, putative |
Plasmodium yoelii | PY03514 | Drosophila melanogaster CG13900 gene product |
Saccharomyces cerevisiae | YML049C | Rse1p |
Schistosoma japonicum | Sjp_0025810 | Splicing factor 3B subunit 3, putative |
Schmidtea mediterranea | mk4.018922.00 | Splicing factor 3B subunit 3 |
Schmidtea mediterranea | mk4.043164.00 | Splicing factor 3B subunit 3 |
Schmidtea mediterranea | mk4.039880.00 | Splicing factor 3B subunit 3 |
Schmidtea mediterranea | mk4.005874.00 | Splicing factor 3B subunit 3 |
Schmidtea mediterranea | mk4.039880.01 | Splicing factor 3B subunit 3 |
Toxoplasma gondii | TGME49_230960 | splicing factor 3b, subunit 3, putative |
Theileria parva | TP04_0182 | hypothetical protein |
Trichomonas vaginalis | TVAG_013050 | spliceosomal protein sap, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_K02F2.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_K02F2.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_K02F2.3 | Caenorhabditis elegans | sterile | wormbase |
YML049C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1449400 | Plasmodium berghei | Essential | plasmo |
TGME49_230960 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | splicing factor 3b, subunit 3, 130kDa | Compounds | References |